Accéder au contenu
MilliporeSigma
Toutes les photos(1)

Principaux documents

1099008

USP

Cephalexin

United States Pharmacopeia (USP) Reference Standard

Synonyme(s) :

Cephalexin monohydrate

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme

Sélectionner une taille de conditionnement

400 MG
579,00 $

579,00 $

Veuillez contacter notre Service Clients pour connaître la disponibilité de ce produit.
Devis pour commande en gros
Toutes les photos(1)

Sélectionner une taille de conditionnement

Changer de vue
400 MG
579,00 $

About This Item

Formule empirique (notation de Hill):
C16H17N3O4S · H2O
Numéro CAS:
23325-78-2
Poids moléculaire :
365.40
Numéro MDL:
MFCD00167148
Code UNSPSC :
41116107
Nomenclature NACRES :
NA.24

579,00 $

Veuillez contacter notre Service Clients pour connaître la disponibilité de ce produit.
Devis pour commande en gros

Qualité

pharmaceutical primary standard

Famille d'API

cephalexin

Fabricant/nom de marque

USP

Application(s)

pharmaceutical (small molecule)

Format

neat

Chaîne SMILES 

S1[C@H]2N(C(=C(C1)C)C(=O)O)C(=O)[C@H]2NC(=O)[C@H](N)c3ccccc3.O

InChI

1S/C16H17N3O4S.H2O/c1-8-7-24-15-11(14(21)19(15)12(8)16(22)23)18-13(20)10(17)9-5-3-2-4-6-9;/h2-6,10-11,15H,7,17H2,1H3,(H,18,20)(H,22,23);1H2/t10-,11-,15-;/m1./s1

Clé InChI

AVGYWQBCYZHHPN-CYJZLJNKSA-N

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Description générale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Cephalexin USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.
Also, for use with USP monographs such as:
  • Cephalexin Hydrochloride
  • Cephalexin Tablets
  • Cephalexin Capsules
  • Cephalexin for Oral Suspension
  • Cephalexin Tablets for Oral Suspension

Remarque sur l'analyse

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Autres remarques

Sales restrictions may apply.

Code de la classe de stockage

11 - Combustible Solids

Classe de danger pour l'eau (WGK)

WGK 3

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable

Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

Si vous avez besoin d'assistance, veuillez contacter Service Clients

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Les clients ont également consulté

Slide 1 of 8

1 of 8

Spironolactone United States Pharmacopeia (USP) Reference Standard

USP

1619006

Spironolactone

3,5-Dimethylanisole ≥99%

Sigma-Aldrich

D146609

3,5-Dimethylanisole

Nitrofurantoïne United States Pharmacopeia (USP) Reference Standard

USP

1464001

Nitrofurantoïne

Fosfomycin sodium VETRANAL®, analytical standard

Supelco

34089

Fosfomycin sodium

Amoxicillin T trihydrate United States Pharmacopeia (USP) Reference Standard

USP

1031503

Amoxicillin T trihydrate

Metformin hydrochloride United States Pharmacopeia (USP) Reference Standard

USP

1396309

Metformin hydrochloride

Levofloxacin United States Pharmacopeia (USP) Reference Standard

USP

1362103

Levofloxacin

Chloramphénicol ≥98% (HPLC)

Sigma-Aldrich

C0378

Chloramphénicol

G L McCloskey et al.
Cutis, 59(5), 251-254 (1997-05-01)
The ampicillin rash occurring in cases of infectious mononucleosis is well documented. Similar phenomena have also been observed with other antibiotics. The case of a patient with infectious mononucleosis treated with cephalexin who later showed a rash is presented and
C W Derrick et al.
Postgraduate medical journal, 59 Suppl 5, 43-46 (1983-01-01)
Cephalexin remains an effective and highly useful antibiotic for the treatment of streptococcal and staphylococcal skin infections. Twelve years of experience have not diminished its efficacy, and cure rates of 90% or higher continue to be achieved. Its resistance to
Viviane Jusot et al.
Journal of tropical pediatrics, 60(3), 223-230 (2014-02-18)
Bordetella pertussis still poses an important health threat in developing countries. In Niger, notified pertussis cases are few despite the low diphtheria-tetanus-pertussis/pentavalent vaccine coverage. We aimed to estimate the prevalence of B. pertussis in children aged <5 years consulting at
R N Jones et al.
Postgraduate medical journal, 59 Suppl 5, 9-15 (1983-01-01)
The present report reviews the significant in vitro characteristics of cephalexin based on data published since 1967 (Wick, 1967). Whenever possible, current data on the action spectrum of cephalexin are compared with previous results, and the significance of in vitro
M J Raff
Postgraduate medical journal, 59 Suppl 5, 32-39 (1983-01-01)
Cephalexin has had 12 years of extensive clinical usage in the management of respiratory tract and other infections. It is reliably absorbed from the gastrointestinal tract and reaches therapeutic levels in serum and tissues. Toxicity and adverse side effects are
Afficher tous les articles scientifiques apparentés

Questions

Reviews

No rating value

Active Filters

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique